The decoding of the human genome has revolutionized our understanding of genetic diseases and disorders, and their diagnostics. The greatest hope, however, was that with this knowledge, we would be able to find cures for hereditary diseases and faulty genes especially in cancer. How far have we come since? And what are the obstacles in developing therapeutics that alter gene expression? How do we direct these therapeutics to their sites of action? And how can we decrease side effects? This book addresses all these questions. The latest and most exciting advances in the delivery of oligonucleoti
